loading page

TREATMENT OF RECURRENT PEDIATRIC MYELODYSPLASTIC SYNDROME POST HEMATOPOIETIC STEM CELL TRANSPLANTATION
  • +10
  • Franziska Wachter,
  • Yana Pikman,
  • Jacob Bledsoe,
  • Malika Kapadia,
  • Susanne Baumeister,
  • Jared Rowe,
  • Akiko Shimamura,
  • Andrew E. Place,
  • Susan Prockop,
  • Jennifer Whangbo,
  • Leslie Lehmann,
  • John Horan,
  • Jessica Pollard
Franziska Wachter
Dana-Farber Cancer Institute Department of Pediatric Oncology

Corresponding Author:franziska_wachter@dfci.harvard.edu

Author Profile
Yana Pikman
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author Profile
Jacob Bledsoe
Boston Children's Hospital Department of Pathology
Author Profile
Malika Kapadia
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author Profile
Susanne Baumeister
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author Profile
Jared Rowe
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author Profile
Akiko Shimamura
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author Profile
Andrew E. Place
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author Profile
Susan Prockop
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author Profile
Jennifer Whangbo
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author Profile
Leslie Lehmann
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author Profile
John Horan
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author Profile
Jessica Pollard
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author Profile
15 Oct 2023Submitted to Clinical Case Reports
17 Oct 2023Submission Checks Completed
17 Oct 2023Assigned to Editor
17 Oct 2023Reviewer(s) Assigned
23 Oct 2023Review(s) Completed, Editorial Evaluation Pending
24 Oct 2023Editorial Decision: Revise Minor
26 Oct 20231st Revision Received
27 Oct 2023Submission Checks Completed
27 Oct 2023Assigned to Editor
27 Oct 2023Review(s) Completed, Editorial Evaluation Pending
01 Nov 2023Editorial Decision: Accept